ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ UNG THƯ TUYẾN GIÁP THỂ BIỆT HÓA ĐÃ PHẪU THUẬT GIAI ĐOẠN DI CĂN BẰNG I-131 TẠI BỆNH VIỆN UNG BƯỚU NGHỆ AN

Abstract

Objective: Comment on some clinical and paraclinical characteristics, evaluate treatment results of patients with metastatic differentiated thyroid cancer treated with I-131 at Nghe an Oncology Hospital. Subject and method:  Cross sectional study, 230 patients with metastatic differentiated thyroid carcinoma who underwent total thyroidectomy were treated with I-131 at the Department of Nuclear Medicine, Nghe an Oncology Hospital from January 2018 to May 2021. Results:  The common age group is 21-55 years old and most of the patients are of working age, the average age is 47.5 ± 12.1. The rate of women with thyroid cancer is 5,5 times higher than the number of male patients, the pathological results show that papillary cancer accounts for the highest rate. In patients with lymph node metastasis who have undergone surgery, the rate of complete response is higher than in patients with nodal metastasis who have not had surgery. Therefore, in patients with cervical lymph node metastasis, lymph node dissection should be performed before radioactive iodine treatment. Cases of patients with lung and bone metastases often need to be treated with a large dose of I-131, but the treatment effect is not high.